21st August 2018 Content supplied by: Microbiologics, Inc.
Microbiologics Appoints Mark Ellingson as Director of Business Development
Mcrobiologics, Inc. has appointed Mark Ellingson as Director of Business Development overseeing the business-to-business partnerships for Microbiologics and its subsidiaries, Virapur and Gibson Bioscience. Ellingson will continue to lead the Microbiologics Business Solutions division, a key component of the company dedicated to partnering with diagnostic and life science companies to develop customized biological controls and services. In his new role, Ellingson will leverage the combined expertise from the company’s teams at Microbiologics, Virapur, and Gibson Bioscience to continue building upon the strong growth from its rapidly expanding offering.
“When I started at Microbiologics, we set out on a mission to utilize our quality control expertise to help manufactures develop custom, user-friendly controls for their instruments and assays,” said Ellingson. “Over the past four years, our team has succeeded in this mission by constantly aiming to exceed the expectations of our partners and customers. I look forward to continuing on this path by strengthening our current partnerships, fostering new relationships, and always designing and delivering the highest quality products and services for our customers.”
Prior to joining the Microbiologics team in 2014 as the Senior Business Development Manager, Ellingson gained extensive experience in the medical device and molecular diagnostics fields through roles at Roche Diagnostics, Baxter International, and Beckman Coulter. As the Director of Business Development, Ellingson will oversee Microbiologics’ wide range of business-to-business solutions including virology research and development, microbiome development, fermentation, and a wide array of specialty products tailored to the specific needs of its customers.
“Focusing on business-to-business partnerships to develop products and services that help our customers ensure accurate results will continue to be a top priority for our team,” said Brad Goskowicz, Chief Executive Officer. “I am confidence that Mark will continue to demonstrate the strong leadership and resourcefulness we need to expand our product and service offerings for established and emerging industries.”
Date Published: 21st August 2018
Source article link: http://www.microbiologics.com
Microbiologics Expands Its Molecular Diagnostics
Test-Ready Control Strains